Roche’s Faricimab improves and maintains vision in two leading causes of vision loss: Lancet EP News Bureau Jan 26, 2022 All four studies met their primary endpoints, showing that people treated with Faricimab up to every four months achieved…
Roche Pharma achieves several milestones in Q3 EP News Bureau Oct 20, 2021 The company announced several key development milestones in neuroscience, ophthalmology, oncology and COVID-19, along with some…
FDA accepts application for Roche’s Faricimab EP News Bureau Jul 29, 2021 If approved, Faricimab would be the first and only medicine designed to target two distinct pathways that drive retinal diseases…
